RESEARCH & DEVELOPMENT
APPLYING SCIENCE IN SKINCARE
MAVI is positioned at the forefront of cosmeceutical development and solid R&D is at the base of all MAVI products. In fact, MAVI distinguishes itself from other Italian SMEs by investing 15% of annual turnover in R&D. The Company develops all its products through biological research in its own laboratories and clinical studies at international level.By its studies, MAVI R&D laboratories have developed a series of innovative delivery systems (vehicles) patented under the MDS brand (MAVI Diffusion System) and necessary to ameliorate the penetration (delivery) of the active ingredients through the skin layers. MDS vehicles are micro and nanoemulsions which can facilitate the delivery of ingredients with various properties e.g. substances with anti-
The Centre for Nanoscience, a Nanotechnology Research Group set up by MAVI, has permitted the company to perfect its unique delivery system technology rendering products more efficacious and effectively differentiating them from market competitors.
As a result of this research the methodology for the extraction of chitin in its crystalline form, Chitin Nanofibrils (CN), was patented worldwide by MAVI.
CN is the second most abundant natural polysaccharide and can be used as a carrier molecule for numerous active ingredients. It is a sugar-
The innovative character of MAVI is represented by the unique line of products characterized by the use of these Chitin Nanofibril (CN) which ,being an electropositive polymer, form complexes with electronegative polymers ,as hyaluronic acid,entrapping numerous well-
With the use of CN it is possible to obtain several types of block polymers which can encapsulate or entrap a series of active ingredients including vitamins, antioxidants, sun filters ,and immunomodulating compounds.
These block polymers can also be mechanically transformed into micro and nanoparticles for use in emulsions, cosmetic gels, biomedical textiles and biofilm for foodstuffs packaging.
CN demonstrates excellent potential for use in the production of transparent film and textiles with intrinsic bacteriostatic and mycostatic properties with multiple potential uses including bio-
MAVI has conducted in vitro and in vivo studies to observe the activity of many CN vehicles created for a series of products with various scopes and the results of these studies have been published and presented at international level.
Thanks to these data the EU funded project BIOMIMETIC has been approved to begin in 2012. It will allow MAVI to develop different categories of new textiles for biomedical use.
Another EU project, n-
Such biopolymers are an ideal solution as they are skin-